Inside The Development Of An AAV8 Production Platform Designed For Scale

Adeno-associated virus (AAV) vectors play a crucial role in gene therapy and offer promising avenues for treating various genetic disorders. However, their production is fraught with significant challenges, such as scalability, low recovery rates, and the need for effective separation of empty and full capsids. This webinar introduces a comprehensive AAV8 production platform, developed in collaboration with CDMO Matica Biotechnology, which addresses these industry pain points through innovative upstream and downstream processes.

Discover how this approach ensured that the production process remained efficient and scalable to meet the high-yield demands of AAV production.